A Patient-Oriented Research Mentoring Program in Tobacco Dependence and Implementation Science Research
3 other identifiers
interventional
500
1 country
1
Brief Summary
The objective of this trial is to evaluate the effectiveness of "nudges" to clinicians, patients, or both in increasing referral to, and engagement with, tobacco use treatment services (TUTS) for HIV patients versus usual care. This will be a four-arm pragmatic cluster randomized clinical trial. The investigators hypothesize that each of the implementation strategy arms will significantly increase TUTS referral and engagement compared to usual care and that the combination of nudges to clinicians and to patients will be the most effective.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable hiv
Started Dec 2023
Typical duration for not_applicable hiv
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 1, 2023
CompletedFirst Posted
Study publicly available on registry
May 10, 2023
CompletedStudy Start
First participant enrolled
December 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
February 1, 2027
June 1, 2026
May 1, 2026
3.2 years
May 1, 2023
May 28, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Rate of referral to tobacco treatment
Defined as the number of TUTS orders signed in the electronic medical record, divided by the total number of pended orders
through study completion, up to one year
Rate of engagement in tobacco treatment
Defined as the total number of patients who enroll in a tobacco treatment trial, complete at least one session with a tobacco treatment specialist from the investigators' cessation program, or use a tobacco medication divided by the total number of patients
through study completion, up to one year
Study Arms (4)
Usual Care
NO INTERVENTIONClinicians and patients will receive no further interventions beyond usual practice.
Clinician Nudge
EXPERIMENTALClinicians will receive a nudge via a Best Practice Alert within the electronic medical record.
Patient Nudge
EXPERIMENTALPatients will receive a message sent through the patient portal or via text.
Combined Nudge: Clinician and Patient Nudge
EXPERIMENTALBoth the clinician nudge and the patient nudge will be used.
Interventions
The clinician nudge will use the BPA functionality within the electronic medical record to deliver a message with a defaulted option to refer to the health system's tobacco treatment program. Changing the default to "no referral" will require an explanation using the options provided or by entering free text.
The patient nudge will deliver a message within 72 hours of a patient's next scheduled clinic visit. The message will be delivered through the Penn patient portal (MyPennMedicine) or by text with security measures for privacy.
Eligibility Criteria
You may qualify if:
- Clinician participants must meet the following criteria for enrollment:
- Penn Division of Infectious Disease
- Prescribing authority in Pennsylvania (i.e., physician, nurse practitioner, physician assistant)
- Clinical oversight of HIV patients for the past six months
- English-speaking (messages will be in English)
- Patient participants must be diagnosed with HIV and report current tobacco smoking (self-report daily smoking for last 6 months)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Abramson Cancer Center at Penn Medicinelead
- National Institute on Drug Abuse (NIDA)collaborator
- University of Pennsylvaniacollaborator
Study Sites (1)
University of Pennsylvania
Philadelphia, Pennsylvania, 19104, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- FACTORIAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 1, 2023
First Posted
May 10, 2023
Study Start
December 1, 2023
Primary Completion (Estimated)
February 1, 2027
Study Completion (Estimated)
February 1, 2027
Last Updated
June 1, 2026
Record last verified: 2026-05